{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:43:20Z","timestamp":1791729800653,"version":"4.3.4"},"reference-count":353,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"abstract":"<jats:p>The genetic mechanisms underlying functional hyperandrogenism and the polycystic ovary syndrome (PCOS) remain largely unknown. Given the large number of genetic variants found in association with these disorders, the emerging picture is that of a complex multigenic trait in which environmental influences play an important role in the expression of the hyperandrogenic phenotype.<\/jats:p><jats:p>Among others, genomic variants in genes related to the regulation of androgen biosynthesis and function, insulin resistance, and the metabolic syndrome, and proinflammatory genotypes may be involved in the genetic predisposition to functional hyperandrogenism and PCOS.<\/jats:p><jats:p>The elucidation of the molecular genetic basis of these disorders has been burdened by the heterogeneity in the diagnostic criteria used to define PCOS, the limited sample size of the studies conducted to date, and the lack of precision in the identification of ethnic and environmental factors that trigger the development of hyperandrogenic disorders. Progress in this area requires adequately sized multicenter collaborative studies after standardization of the diagnostic criteria used to classify hyperandrogenic patients, in whom modifying environmental factors such as ethnicity, diet, and lifestyle are identified with precision.<\/jats:p><jats:p>In addition to classic molecular genetic techniques such as linkage analysis in the form of a whole-genome scan and large case-control studies, promising genomic and proteomic approaches will be paramount to our understanding of the pathogenesis of functional hyperandrogenism and PCOS, allowing a more precise prevention, diagnosis, and treatment of these prevalent disorders.<\/jats:p>","DOI":"10.1210\/er.2004-0004","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T22:07:42Z","timestamp":1111788462000},"page":"251-282","source":"Crossref","is-referenced-by-count":324,"title":["The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"26","author":[{"given":"He\u0301ctor F.","family":"Escobar-Morreale","sequence":"first","affiliation":[{"name":"Departments of Endocrinology (H.F.E.-M., M.L.-R.) Hospital Ramo\u0301n y Cajal, Madrid, Spain E-28034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Luque-Rami\u0301rez","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (H.F.E.-M., M.L.-R.) Hospital Ramo\u0301n y Cajal, Madrid, Spain E-28034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301 L.","family":"San Milla\u0301n","sequence":"additional","affiliation":[{"name":"Molecular Genetics (J.L.S.M.), Hospital Ramo\u0301n y Cajal, Madrid, Spain E-28034"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614065270600_R1","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","article-title":"Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.","volume":"84","author":"Carmina","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome.","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614065270600_R3","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071614065270600_R4","first-page":"51","article-title":"Le virilisme pilaire et son association a\u0300 l\u2032insuffisance glycolytique. (Diabe\u0300te des femmes a barbe).","volume":"86","author":"Achard","year":"1921","journal-title":"Bull Acad Natl Med"},{"key":"2020071614065270600_R5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries.","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614065270600_R6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0889-8529(05)70079-7","article-title":"Cardiovascular consequences of polycystic ovary syndrome.","volume":"28","author":"Amowitz","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614065270600_R7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0889-8545(05)70189-3","article-title":"Cardiovascular risk in women with polycystic ovary syndrome.","volume":"28","author":"Talbott","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2020071614065270600_R8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614065270600_R9","first-page":"377","author":"Zawadzki","year":"1992"},{"key":"2020071614065270600_R10","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/humrep\/17.10.2495","article-title":"What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome.","volume":"17","author":"Homburg","year":"2002","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R13","first-page":"347","article-title":"Idiopathic hirsutism.","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"issue":"Suppl 5","key":"2020071614065270600_R14","first-page":"1303","article-title":"Family history as a risk factor for the polycystic ovary syndrome","volume":"13","author":"Azziz","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614065270600_R15","first-page":"707","article-title":"Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome.","volume":"129","author":"Benitez","year":"2001","journal-title":"Rev Med Chil"},{"key":"2020071614065270600_R16","first-page":"2027","article-title":"Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first-degree relatives.","volume":"86","author":"Colilla","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)80053-9","article-title":"The genetics of polycystic ovary syndrome.","volume":"98","author":"Legro","year":"1995","journal-title":"Am J Med"},{"key":"2020071614065270600_R18","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/humrep\/12.12.2641","article-title":"The genetic basis of polycystic ovary syndrome.","volume":"12","author":"Franks","year":"1997","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/09513599609012823","article-title":"Genetic and non-genetic theories on the etiology of polycystic ovary syndrome.","volume":"10","author":"Jahanfar","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"2020071614065270600_R20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","article-title":"Evidence for a single gene effect causing polycystic ovaries and male pattern baldness.","volume":"38","author":"Carey","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","article-title":"Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.","volume":"84","author":"Govind","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/humupd\/7.4.405","article-title":"Candidate genes in polycystic ovary syndrome.","volume":"7","author":"Franks","year":"2001","journal-title":"Hum Reprod Update"},{"key":"2020071614065270600_R23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03350784","article-title":"Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?","volume":"21","author":"Holte","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020071614065270600_R24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humupd\/7.1.3","article-title":"Polycystic ovarian disease: heritability and heterogeneity.","volume":"7","author":"Crosignani","year":"2001","journal-title":"Hum Reprod Update"},{"key":"2020071614065270600_R25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0002-9378(15)33704-2","article-title":"Hereditary factors in the Stein-Leventhal syndrome.","volume":"100","author":"Cooper","year":"1968","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614065270600_R26","first-page":"81","article-title":"Hyperthecosis: an inheritable form of polycystic ovarian disease.","volume":"11","author":"Wilroy Jr","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2020071614065270600_R27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9378(71)90550-3","article-title":"Familial polycystic ovarian hyperthecosis: a study of two families.","volume":"11","author":"Givens","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614065270600_R28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0889-8529(18)30409-2","article-title":"Familial polycystic ovarian disease.","volume":"17","author":"Givens","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614065270600_R29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1979.tb03077.x","article-title":"The inheritance of polycystic ovarian disease and a possible relationship to premature balding.","volume":"11","author":"Ferriman","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1988.tb03707.x","article-title":"Familial polycystic ovaries: a genetic disease?","volume":"29","author":"Hague","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000293493","article-title":"Familial clustering in the polycystic ovarian syndrome.","volume":"28","author":"Lunde","year":"1989","journal-title":"Gynecol Obstet Invest"},{"key":"2020071614065270600_R32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R33","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614065270600_R34","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R35","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(16)58687-7","article-title":"Hyperinsulinemia is common in family members of women with polycystic ovary syndrome.","volume":"66","author":"Norman","year":"1996","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R37","first-page":"583","article-title":"Study on parents phenotypes in women with polycystic ovary syndrome.","volume":"35","author":"Mao","year":"2000","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"(Suppl 5)","key":"2020071614065270600_R38","first-page":"1307","volume":"13","author":"Legro RS 2000 Is there a male phenotype in polycystic ovary syndrome families?","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614065270600_R39","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0015-0282(16)57412-3","article-title":"A twin study of polycystic ovary syndrome.","volume":"63","author":"Jahanfar","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09513599709152521","article-title":"A twin study of polycystic ovary syndrome and lipids.","volume":"11","author":"Jahanfar","year":"1997","journal-title":"Gynecol Endocrinol"},{"key":"2020071614065270600_R42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2265.2001.01399.x","article-title":"Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.","volume":"55","author":"Iba\u0301n\u0303ez","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R43","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life.","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"key":"2020071614065270600_R44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(05)78232-5","article-title":"Length of gestation and polycystic ovaries in adulthood.","volume":"351","author":"Edozien","year":"1998","journal-title":"Lancet"},{"key":"2020071614065270600_R45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(05)78231-3","article-title":"Length of gestation and polycystic ovaries in adulthood.","volume":"351","author":"van Hooff","year":"1998","journal-title":"Lancet"},{"key":"2020071614065270600_R46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome.","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071614065270600_R47","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R48","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R49","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R50","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614065270600_R51","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diab.42.10.1462","article-title":"Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.","volume":"42","author":"Dunaif","year":"1993","journal-title":"Diabetes"},{"key":"2020071614065270600_R52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1479-828X.2001.tb01210.x","article-title":"The impact of ethnicity on the presentation of polycystic ovarian syndrome.","volume":"41","author":"Williamson","year":"2001","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"2020071614065270600_R53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2265.1998.00492.x","article-title":"Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.","volume":"49","author":"Rodin","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2003-030666","article-title":"Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome.","volume":"89","author":"Kasim-Karakas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R56","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJMra012240","article-title":"Genomic medicine\u2013a primer.","volume":"347","author":"Guttmacher","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R57","first-page":"1835","article-title":"Genetic studies of complex diseases: let the reader beware.","volume":"11","author":"Econs","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071614065270600_R58","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","article-title":"The future of genetic studies of complex human diseases.","volume":"273","author":"Risch","year":"1996","journal-title":"Science"},{"key":"2020071614065270600_R59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/79839","article-title":"Guilt by association.","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat Genet"},{"key":"2020071614065270600_R60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ng1195-241","article-title":"Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.","volume":"11","author":"Lander","year":"1995","journal-title":"Nat Genet"},{"key":"2020071614065270600_R61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/301741","article-title":"Significance levels in complex inheritance.","volume":"62","author":"Morton","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R62","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/302073","article-title":"Methods of linkage analysis\u2013and the assumptions underlying them.","volume":"63","author":"Elston","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/9642","article-title":"Prospects for whole-genome linkage disequilibrium mapping of common disease genes.","volume":"22","author":"Kruglyak","year":"1999","journal-title":"Nat Genet"},{"key":"2020071614065270600_R64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0511(02)00052-2","article-title":"Gene finding strategies.","volume":"61","author":"Vink","year":"2002","journal-title":"Biol Psychol"},{"key":"2020071614065270600_R65","first-page":"175","article-title":"Clinical genetics, genetic counseling.","author":"Kelly","year":"1986","edition":"2nd ed."},{"key":"2020071614065270600_R66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-0760(99)00043-6","article-title":"Heritability and the risk of developing androgen excess.","volume":"69","author":"Kashar-Miller","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071614065270600_R67","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(02)03275-2","article-title":"Molecular progress in infertility: polycystic ovary syndrome.","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R68","first-page":"506","article-title":"Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).","volume":"52","author":"Spielman","year":"1993","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R69","first-page":"983","article-title":"The TDT and other family-based tests for linkage disequilibrium and association.","volume":"59","author":"Spielman","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R70","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng0495-347","article-title":"Positional cloning moves from perditional to traditional.","volume":"9","author":"Collins","year":"1995","journal-title":"Nat Genet"},{"key":"2020071614065270600_R71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/edrv.23.3.0469","article-title":"Genetic approaches to unraveling reproductive disorders: example of bedside to bench research in the genomic era.","volume":"23","author":"Seminara","year":"2002","journal-title":"Endocr Rev"},{"key":"2020071614065270600_R72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0889-8529(05)70075-X","article-title":"Polycystic ovary syndrome. Phenotype to genotype.","volume":"28","author":"Legro","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614065270600_R73","first-page":"135","article-title":"Linkage analysis of \u201cnecessary\u201d disease loci versus \u201csusceptibility\u201d loci.","volume":"52","author":"Greenberg","year":"1993","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R74","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/bmj.310.6977.428","article-title":"Fetal and infant growth and cardiovascular risk factors in women.","volume":"310","author":"Fall","year":"1995","journal-title":"BMJ"},{"key":"2020071614065270600_R75","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.303.6809.1019","article-title":"Fetal and infant growth and impaired glucose tolerance at age 64.","volume":"303","author":"Hales","year":"1991","journal-title":"BMJ"},{"key":"2020071614065270600_R76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.297.6641.134-b","article-title":"Low birth weight and hypertension.","volume":"297","author":"Barker","year":"1988","journal-title":"BMJ"},{"key":"2020071614065270600_R77","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.","volume":"298","author":"Barker","year":"1989","journal-title":"BMJ"},{"key":"2020071614065270600_R78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.301.6746.259","article-title":"Fetal and placental size and risk of hypertension in adult life.","volume":"301","author":"Barker","year":"1990","journal-title":"BMJ"},{"key":"2020071614065270600_R79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bmj.311.6998.171","article-title":"Fetal origins of coronary heart disease.","volume":"311","author":"Barker","year":"1995","journal-title":"BMJ"},{"key":"2020071614065270600_R80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00399954","article-title":"Fetal growth and impaired glucose tolerance in men and women.","volume":"36","author":"Phipps","year":"1993","journal-title":"Diabetologia"},{"key":"2020071614065270600_R81","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00125-001-0757-6","article-title":"Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals.","volume":"45","author":"Eriksson","year":"2002","journal-title":"Diabetologia"},{"key":"2020071614065270600_R82","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(98)07546-1","article-title":"The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease.","volume":"353","author":"Hattersley","year":"1999","journal-title":"Lancet"},{"key":"2020071614065270600_R83","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0598-98","article-title":"Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.","volume":"19","author":"Dunger","year":"1998","journal-title":"Nat Genet"},{"key":"2020071614065270600_R84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/295031a0","article-title":"The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences.","volume":"295","author":"Bell","year":"1982","journal-title":"Nature"},{"key":"2020071614065270600_R85","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ng0395-293","article-title":"The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription.","volume":"9","author":"Kennedy","year":"1995","journal-title":"Nat Genet"},{"key":"2020071614065270600_R86","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmj.288.6411.96","article-title":"Diabetic hypertriglyceridaemia and related 5\u2032 flanking polymorphism of the human insulin gene.","volume":"288","author":"Jowett","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2020071614065270600_R87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2362.1992.tb01461.x","article-title":"Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5\u2032 flanking region of the human insulin gene.","volume":"22","author":"Weaver","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"2020071614065270600_R88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.genet.30.1.343","article-title":"Human type 1 diabetes and the insulin gene: principles of mapping polygenes.","volume":"30","author":"Bennett","year":"1996","journal-title":"Annu Rev Genet"},{"key":"2020071614065270600_R89","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/6775","article-title":"The insulin gene VNTR, type 2 diabetes and birth weight.","volume":"21","author":"Ong","year":"1999","journal-title":"Nat Genet"},{"issue":"Suppl 6","key":"2020071614065270600_R90","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1515\/jpem-2000-s616","article-title":"Thrifty genotypes and phenotypes in the pathogenesis of type 2 diabetes mellitus","volume":"13","author":"Ong","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614065270600_R91","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.","volume":"83","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R92","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03350781","article-title":"Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.","volume":"21","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020071614065270600_R93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1651-2227.1999.tb14407.x","article-title":"Endocrinology and metabolism after premature pubarche in girls.","volume":"88","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"Acta Paediatr Suppl"},{"issue":"Suppl 5","key":"2020071614065270600_R94","first-page":"1261","article-title":"Precocious pubarche in girls and the development of androgen excess","volume":"13","author":"Iba\u0301n\u0303ez","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614065270600_R95","first-page":"671","article-title":"Premature adrenarche\u2013normal variant or forerunner of adult disease?","volume":"21","author":"Iba\u0301n\u0303ez","year":"2000","journal-title":"Endocr Rev"},{"key":"2020071614065270600_R96","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence.","volume":"84","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2265.2000.01133.x","article-title":"Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.","volume":"53","author":"Iba\u0301n\u0303ez","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R98","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1542\/peds.102.3.e36","article-title":"Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome","volume":"102","author":"Banerjee","year":"1998","journal-title":"Pediatrics"},{"key":"2020071614065270600_R99","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1210\/jcem.84.11.6106","article-title":"Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women.","volume":"84","author":"Jaquet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","article-title":"Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms.","volume":"27","author":"Laitinen","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071614065270600_R101","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1210\/jcem.86.12.8093","article-title":"Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence.","volume":"86","author":"Iba\u0301n\u0303ez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R102","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.50.9.2164","article-title":"Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome.","volume":"50","author":"El Mkadem","year":"2001","journal-title":"Diabetes"},{"key":"2020071614065270600_R103","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1210\/jc.2002-020216","article-title":"Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R104","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0015-0282(02)04238-3","article-title":"Increased frequency of the G972R variant of the insulin receptor substrate-1 (IRS-1) gene among girls with a history of precocious pubarche.","volume":"78","author":"Iba\u0301n\u0303ez","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R105","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/hmg\/10.17.1753","article-title":"Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes.","volume":"10","author":"Lin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0015-0282(03)00506-5","article-title":"Frequency of the T228A polymorphism in the SORBS1 gene in children with premature pubarche and in adolescent girls with hyperandrogenism.","volume":"80","author":"Witchel","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R107","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJM199508103330604","article-title":"Association of a polymorphism in the \u03b23-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.","volume":"333","author":"Widen","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R108","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0015-0282(99)00568-3","article-title":"No association between body mass index and \u03b23-adrenergic receptor variant (W64R) in children with premature pubarche and adolescent girls with hyperandrogenism.","volume":"73","author":"Witchel","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R109","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s001250100629","article-title":"Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-\u03b32 (PPAR-\u03b32) gene in relation to insulin sensitivity among glucose tolerant Caucasians.","volume":"44","author":"Ek","year":"2001","journal-title":"Diabetologia"},{"key":"2020071614065270600_R110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0015-0282(01)01982-3","article-title":"Inconsistent effects of the proline12 \u2013&gt; alanine variant of the peroxisome proliferator-activated receptor-\u03b32 gene on body mass index in children and adolescent girls.","volume":"76","author":"Witchel","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R111","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/mgme.1998.2715","article-title":"Variants of the type II 3\u03b2-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents.","volume":"64","author":"Nayak","year":"1998","journal-title":"Mol Genet Metab"},{"key":"2020071614065270600_R112","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bmme.1997.2632","article-title":"Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.","volume":"62","author":"Witchel","year":"1997","journal-title":"Biochem Mol Med"},{"issue":"Suppl 5","key":"2020071614065270600_R113","first-page":"1315","article-title":"The role of heterozygosity for CYP21 in the polycystic ovary syndrome","volume":"13","author":"Witchel","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614065270600_R114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1083-3188(98)70132-9","article-title":"17\u03b1-Hydroxylase\/17,20-lyase dysregulation is not caused by mutations in the coding regions of CYP17.","volume":"11","author":"Witchel","year":"1998","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2020071614065270600_R115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(00)01798-2","article-title":"Candidate gene analysis in premature pubarche and adolescent hyperandrogenism.","volume":"75","author":"Witchel","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R116","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2002-021791","article-title":"Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism.","volume":"88","author":"Iba\u0301n\u0303ez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R117","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1515\/JPEM.2003.16.5.719","article-title":"Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism.","volume":"16","author":"Tomboc","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071614065270600_R118","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614065270600_R119","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)53510-9","article-title":"Dysregulation of cytochrome P450c 17\u03b1 as the cause of polycystic ovarian syndrome.","volume":"53","author":"Rosenfield","year":"1990","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R120","first-page":"1686","article-title":"Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.","volume":"79","author":"Rosenfield","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R121","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0015-0282(16)56940-4","article-title":"Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperandrogenism: role of adrenal and ovarian cytochrome P450c17\u03b1.","volume":"62","author":"Escobar-Morreale","year":"1994","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R122","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0015-0282(97)81362-3","article-title":"Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism.","volume":"67","author":"Escobar-Morreale","year":"1997","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R123","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0026-0495(97)90077-9","article-title":"Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?","volume":"46","author":"Escobar-Morreale","year":"1997","journal-title":"Metabolism"},{"key":"2020071614065270600_R124","first-page":"2304","article-title":"Differential activity of the cytochrome P450 17\u03b1-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.","volume":"85","author":"Wickenheisser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R125","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/3.10.1873","article-title":"Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.","volume":"3","author":"Carey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2265.1997.1450937.x","article-title":"The 17\u03b1-hydroxylase\/17,20 lyase gene (CYP17) and polycystic ovary syndrome.","volume":"46","author":"Franks","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R127","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0950-351X(96)80057-7","article-title":"Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17\u03b1.","volume":"10","author":"Franks","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"2020071614065270600_R128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0015-0282(98)00512-3","article-title":"Polymorphism T\u2013&gt;C (\u221234 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome.","volume":"71","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R129","first-page":"4174","article-title":"5\u2032 Polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries.","volume":"81","author":"Gharani","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R130","first-page":"123","article-title":"Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5\u2032-UTR in patients with polycystic ovarian syndrome.","volume":"15","author":"Marszalek","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"2020071614065270600_R131","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2265.1997.8700880.x","article-title":"Frequency of a polymorphism in the regulatory region of the 17\u03b1-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states.","volume":"46","author":"Techatraisak","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R132","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614065270600_R133","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03346901","article-title":"CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation.","volume":"20","author":"Liovic","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"2020071614065270600_R134","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(98)00177-4","article-title":"Role of cytochrome P450c17 in polycystic ovary syndrome.","volume":"145","author":"Qin","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"2020071614065270600_R135","first-page":"4338","article-title":"Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome.","volume":"85","author":"Martens","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R136","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2020071614065270600_R137","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R138","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries.","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R139","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/1464727002000198731","article-title":"Pathogenesis of polycystic ovary syndrome: evidence for a genetically determined disorder of ovarian androgen production.","volume":"3","author":"Franks","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"2020071614065270600_R140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R141","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(99)00628-7","article-title":"Microsatellite polymorphism (tttta) at \u2212528 base pairs of gene CYP11a influences hyperandrogenemia in patients with polycystic ovary syndrome.","volume":"73","author":"Diamanti-Kandarakis","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R142","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(01)02999-5","article-title":"Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17\u03b1-hydroxylase\/C(17\u201320) lyase promoters.","volume":"77","author":"Daneshmand","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R143","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0015-0282(01)01677-6","article-title":"Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism.","volume":"75","author":"San Milla\u0301n","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R144","first-page":"1746","article-title":"Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women.","volume":"86","author":"Calvo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R145","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1210\/jc.2003-031640","article-title":"Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.","volume":"89","author":"Gaasenbeek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R146","first-page":"400","article-title":"Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.","volume":"80","author":"Azziz","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R147","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0015-0282(99)00317-9","article-title":"The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.","volume":"72","author":"Escobar-Morreale","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R148","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2265.1990.tb00880.x","article-title":"HLA associations in patients with polycystic ovaries and in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.","volume":"32","author":"Hague","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R149","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2265.1990.tb03887.x","article-title":"The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives.","volume":"33","author":"Hague","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2002-35373","article-title":"Congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase\/\u03945-\u03944 isomerase deficiency.","volume":"20","author":"Simard","year":"2002","journal-title":"Semin Reprod Med"},{"key":"2020071614065270600_R151","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/jcem-60-3-428","article-title":"Late-onset adrenal steroid 3\u03b2-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.","volume":"60","author":"Pang","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R152","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJM199009273231301","article-title":"ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.","volume":"323","author":"Siegel","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R153","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM199009273231302","article-title":"Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia.","volume":"323","author":"Eldar Geva","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R154","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0002-9378(12)90840-6","article-title":"3\u03b2-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism.","volume":"168","author":"Azziz","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2020071614065270600_R155","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1203\/00006450-199506000-00024","article-title":"Absence of molecular defect in the type II 3\u03b2-hydroxysteroid dehydrogenase (3\u03b2-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3\u03b2-HSD activity.","volume":"37","author":"Chang","year":"1995","journal-title":"Pediatr Res"},{"key":"2020071614065270600_R156","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jc.2003-030934","article-title":"The hormonal phenotype of nonclassic 3\u03b2-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.","volume":"89","author":"Carbunaru","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R157","first-page":"921","article-title":"Substitution mutation C268Y causes 17\u03b2-hydroxysteroid dehydrogenase 3 deficiency.","volume":"86","author":"Lindqvist","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R158","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJM198705213162102","article-title":"Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.","volume":"316","author":"Pang","year":"1987","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R159","first-page":"2855","article-title":"Deleterious missense mutations and silent polymorphism in the human 17\u03b2-hydroxysteroid dehydrogenase 3 gene (HSD17B3).","volume":"83","author":"Moghrabi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R160","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/oxfordjournals.humrep.a019405","article-title":"Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.","volume":"11","author":"Takayama","year":"1996","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/molehr\/4.1.1","article-title":"Aromatase mRNA expression in individual follicles from polycystic ovaries.","volume":"4","author":"Jakimiuk","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"2020071614065270600_R162","first-page":"1739","article-title":"Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.","volume":"82","author":"Mullis","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R163","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11\u03b2-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.","volume":"34","author":"Draper","year":"2003","journal-title":"Nat Genet"},{"key":"2020071614065270600_R164","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071614065270600_R165","first-page":"107","article-title":"Identification of two point mutations in the gene coding luteinizing hormone (LH) \u03b2-subunit, associated with immunologically anomalous LH variants.","volume":"78","author":"Furui","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R166","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/bbrc.1994.1488","article-title":"Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions.","volume":"200","author":"Okuda","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071614065270600_R167","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0015-0282(97)81430-6","article-title":"Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group.","volume":"67","author":"Nilsson","year":"1997","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R168","first-page":"1257","article-title":"Occurrence and biological properties of a common genetic variant of luteinizing hormone.","volume":"80","author":"Haavisto","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R169","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.1995.tb02035.x","article-title":"Prevalence of an immunological LH \u03b2-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome.","volume":"43","author":"Rajkhowa","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R170","first-page":"1711","article-title":"A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.","volume":"84","author":"Tapanainen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R171","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/humrep\/16.6.1058","article-title":"Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans? III. Luteinizing hormone heterogeneity: a medical physiologist\u2019s perspective.","volume":"16","author":"Bergendah","year":"2001","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R172","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2265.1999.00791.x","article-title":"Association of molecular variants of luteinizing hormone with menstrual disorders.","volume":"51","author":"Ramanujam","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R173","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0015-0282(98)00491-9","article-title":"Role of the mutations Trp8 \u21d2 Arg and Ile15 \u21d2 Thr of the human luteinizing hormone \u03b2-subunit in women with polycystic ovary syndrome.","volume":"71","author":"Elter","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R174","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(97)00445-7","article-title":"A new molecular variant of luteinizing hormone associated with female infertility.","volume":"69","author":"Liao","year":"1998","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.ejhg.5200968","article-title":"Influence of missense mutation and silent mutation of LH\u03b2-subunit gene in Japanese patients with ovulatory disorders.","volume":"11","author":"Takahashi","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"2020071614065270600_R176","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0015-0282(00)01616-2","article-title":"Association of AccI polymorphism in the follicle-stimulating hormone \u03b2 gene with polycystic ovary syndrome.","volume":"74","author":"Tong","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R177","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2001-14941","article-title":"Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome.","volume":"33","author":"Tong","year":"2001","journal-title":"Horm Metab Res"},{"key":"2020071614065270600_R178","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0015-0282(00)01673-3","article-title":"Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome.","volume":"75","author":"Takakura","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R179","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0015-0282(99)00225-3","article-title":"Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome.","volume":"72","author":"Cohen","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R180","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/oxfordjournals.humrep.a138693","article-title":"Association of dopamine D2 receptor gene haplotypes with anovulation and fecundity in female Hispanics.","volume":"9","author":"Legro","year":"1994","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R181","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0015-0282(16)57481-0","article-title":"A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female Hispanics.","volume":"63","author":"Legro","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R182","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0015-0282(98)00485-3","article-title":"Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome.","volume":"71","author":"Kahsar-Miller","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R183","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000184778","article-title":"Clinical utility of sex hormone-binding globulin measurement.","volume":"45","author":"Pugeat","year":"1996","journal-title":"Horm Res"},{"key":"2020071614065270600_R184","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI0214060","article-title":"Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction.","volume":"109","author":"Hogeveen","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071614065270600_R185","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1210\/jc.2003-030197","article-title":"Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels.","volume":"88","author":"Xita","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R186","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jc.2002-021553","article-title":"Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women.","volume":"89","author":"Cousin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R187","first-page":"402","article-title":"Escobar-Morreale HF, Analysis of the gene encoding the glucocorticoid receptor (GRL) in hirsute women presenting with functional adrenal hyperandrogenism.","volume-title":"Program of the 82nd Annual Meeting of The Endocrine Society,","author":"Calvo","year":"2000"},{"key":"2020071614065270600_R188","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/mgme.1998.2796","article-title":"Glucocorticoid resistance in premature pubarche and adolescent hyperandrogenism.","volume":"66","author":"Witchel","year":"1999","journal-title":"Mol Genet Metab"},{"key":"2020071614065270600_R189","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0015-0282(00)01620-4","article-title":"A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome.","volume":"74","author":"Kahsar-Miller","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R190","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI115954","article-title":"Molecular genetics of steroid 5\u03b1-reductase 2 deficiency.","volume":"90","author":"Thigpen","year":"1992","journal-title":"J Clin Invest"},{"key":"2020071614065270600_R191","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/354159a0","article-title":"Deletion of steroid 5\u03b1-reductase 2 gene in male pseudohermaphroditism.","volume":"354","author":"Andersson","year":"1991","journal-title":"Nature"},{"key":"2020071614065270600_R192","first-page":"2414","article-title":"5\u03b1-Reductase activity in women with polycystic ovary syndrome.","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R193","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.3353727","article-title":"Cloning of human androgen receptor complementary DNA and localization to the X chromosome.","volume":"240","author":"Lubahn","year":"1988","journal-title":"Science"},{"key":"2020071614065270600_R194","first-page":"264","article-title":"Androgen receptor locus on the human X chromosome: regional localization to Xq11\u201312 and description of a DNA polymorphism.","volume":"44","author":"Brown","year":"1989","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv-11-2-201","article-title":"Steroid receptor family: structure and functions.","volume":"11","author":"Carson-Jurica","year":"1990","journal-title":"Endocr Rev"},{"key":"2020071614065270600_R196","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0888-7543(92)90371-X","article-title":"Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.","volume":"12","author":"Edwards","year":"1992","journal-title":"Genomics"},{"key":"2020071614065270600_R197","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","article-title":"The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.","volume":"22","author":"Chamberlain","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"2020071614065270600_R198","first-page":"701","article-title":"Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgenic characteristics.","volume":"83","author":"Legro","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2020071614065270600_R199","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(98)08413-X","article-title":"Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene.","volume":"354","author":"Dowsing","year":"1999","journal-title":"Lancet"},{"key":"2020071614065270600_R200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/120347549800300103","article-title":"Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne.","volume":"3","author":"Sawaya","year":"1998","journal-title":"J Cutan Med Surg"},{"key":"2020071614065270600_R201","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1210\/jcem.85.9.6832","article-title":"Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries.","volume":"85","author":"Mifsud","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R202","first-page":"1091","article-title":"Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation.","volume":"84","author":"Vottero","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jcem.87.1.8137","article-title":"The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome.","volume":"87","author":"Hickey","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R204","first-page":"1735","article-title":"The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism.","volume":"85","author":"Calvo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R205","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0015-0282(16)57537-2","article-title":"Serum total renin is elevated in women with polycystic ovarian syndrome.","volume":"63","author":"Jaatinen","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R206","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0015-0282(16)57967-9","article-title":"Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism.","volume":"64","author":"Morris","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R207","first-page":"94","article-title":"Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome.","volume":"38","author":"Zhao","year":"2003","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2020071614065270600_R208","first-page":"1237","article-title":"Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.","volume":"81","author":"Iba\u0301n\u0303ez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R209","first-page":"995","article-title":"Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.","volume":"85","author":"Chang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0015-0282(03)00497-7","article-title":"Comparison of various simple insulin sensitivity and \u03b2-cell function indices in lean hyperandrogenemic and normoandrogenemic young hirsute women.","volume":"80","author":"Altuntas","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R211","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jcem.86.1.7274","article-title":"Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus.","volume":"86","author":"Tucci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R212","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0015-0282(02)04570-3","article-title":"Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome.","volume":"79","author":"Villuendas","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R213","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/0026-0495(94)90018-3","article-title":"Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome.","volume":"43","author":"Sorbara","year":"1994","journal-title":"Metabolism"},{"key":"2020071614065270600_R214","first-page":"1979","article-title":"Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome.","volume":"81","author":"Talbot","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R215","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0015-0282(02)04241-3","article-title":"A C\/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome.","volume":"78","author":"Siegel","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R216","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071614065270600_R217","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071614065270600_R218","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/oxfordjournals.humrep.a138773","article-title":"The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome.","volume":"9","author":"Conway","year":"1994","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R219","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00125-003-1126-4","article-title":"Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies.","volume":"46","author":"Jellema","year":"2003","journal-title":"Diabetologia"},{"key":"2020071614065270600_R220","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/hmg\/9.17.2517","article-title":"Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes.","volume":"9","author":"Mammarella","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R221","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071614065270600_R222","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(96)08368-7","article-title":"Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.","volume":"349","author":"Waterworth","year":"1997","journal-title":"Lancet"},{"key":"2020071614065270600_R223","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.2001.01375.x","article-title":"Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight.","volume":"55","author":"Michelmore","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R224","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/11890","article-title":"Transmission ratio distortion at the INS-IGF2 VNTR.","volume":"22","author":"Eaves","year":"1999","journal-title":"Nat Genet"},{"key":"2020071614065270600_R225","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0015-0282(01)03238-1","article-title":"Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women.","volume":"77","author":"Calvo","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R226","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1749-6632.2002.tb04317.x","article-title":"Association of insulin gene VNTR polymorphism with polycystic ovary syndrome.","volume":"967","author":"Vankova","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"2020071614065270600_R227","first-page":"1003","article-title":"Expression of insulin-like growth factor (IGF), IGF-binding protein, and IGF receptor messenger ribonucleic acids in normal and polycystic ovaries.","volume":"81","author":"Voutilainen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R228","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0889-8529(05)70072-4","article-title":"Growth factor action on ovarian function in polycystic ovary syndrome.","volume":"28","author":"Giudice","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614065270600_R229","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.","volume":"89","author":"San Milla\u0301n","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/diabetes.50.3.637","article-title":"A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction.","volume":"50","author":"Vaessen","year":"2001","journal-title":"Diabetes"},{"key":"2020071614065270600_R231","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/nar\/20.6.1427","article-title":"Trinucleotide repeat polymorphism at the human insulin-like growth factor I receptor gene (IGF1R).","volume":"20","author":"Meloni","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"2020071614065270600_R232","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/hmg\/4.10.1945","article-title":"Conservation of a maternal-specific methylation signal at the human IGF2R locus.","volume":"4","author":"Smrzka","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R233","first-page":"2933","article-title":"Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes.","volume":"83","author":"Vafiadis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R234","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.ijo.0800483","article-title":"Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males.","volume":"21","author":"O\u2019Dell","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071614065270600_R235","first-page":"1390","article-title":"Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.","volume":"82","author":"Mesiano","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R236","first-page":"3892","article-title":"Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells.","volume":"81","author":"l\u2019Allemand","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R237","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000184145","article-title":"Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production.","volume":"42","author":"Cara","year":"1994","journal-title":"Horm Res"},{"key":"2020071614065270600_R238","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.","volume":"79","author":"Ghazeeri","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R239","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016294","article-title":"Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.","volume":"15","author":"Nestler","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"2020071614065270600_R241","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R242","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R243","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/humrep\/deg343","article-title":"Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin.","volume":"18","author":"Glueck","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R244","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s001250051243","article-title":"Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-\u03b32 (PPAR-\u03b32): divergent modulating effects on body mass index in obese and lean Caucasian men.","volume":"42","author":"Ek","year":"1999","journal-title":"Diabetologia"},{"key":"2020071614065270600_R245","first-page":"772","article-title":"Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the PPAR\u03b3 gene.","volume":"87","author":"Hara","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R246","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/humrep\/deg128","article-title":"Polymorphism in the peroxisome proliferator-activated receptor-\u03b3 gene in women with polycystic ovary syndrome.","volume":"18","author":"Korhonen","year":"2003","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R247","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-\u03b3 polymorphisms in polycystic ovary syndrome.","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R248","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0891-5849(02)01436-3","article-title":"Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation.","volume":"34","author":"bin Ali","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"2020071614065270600_R249","first-page":"1134","article-title":"The \u2212597 G\u2192A and \u2212174 G\u2192C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism.","volume":"87","author":"Villuendas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R250","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1210\/jcem.87.8.8715","article-title":"The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.","volume":"87","author":"Peral","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R251","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/oby.2003.136","article-title":"Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism.","volume":"11","author":"Escobar-Morreale","year":"2003","journal-title":"Obes Res"},{"key":"2020071614065270600_R252","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/320600","article-title":"Effects of 5\u2032 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.","volume":"68","author":"Brophy","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R253","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0015-0282(03)00571-5","article-title":"Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.","volume":"80","author":"Fenkci","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R254","first-page":"E935","article-title":"Oxidant stress reduces insulin responsiveness in 3T3\u2013L1 adipocytes","volume":"272","author":"Rudich","year":"1997","journal-title":"Am J Physiol"},{"key":"2020071614065270600_R255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(98)00095-1","article-title":"Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.","volume":"139","author":"Mackness","year":"1998","journal-title":"Atherosclerosis"},{"key":"2020071614065270600_R256","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2169\/internalmedicine.37.581","article-title":"Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus.","volume":"37","author":"Sakai","year":"1998","journal-title":"Intern Med"},{"key":"2020071614065270600_R257","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diabetes.49.8.1390","article-title":"Promoter polymorphism T(\u2212107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.","volume":"49","author":"James","year":"2000","journal-title":"Diabetes"},{"key":"2020071614065270600_R258","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/01.ATV.20.11.2441","article-title":"Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.","volume":"20","author":"Jarvik","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071614065270600_R259","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0889-8529(05)70069-4","article-title":"The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks.","volume":"28","author":"Solomon","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614065270600_R260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00394-002-0378-y","article-title":"Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort.","volume":"41","author":"Nieters","year":"2002","journal-title":"Eur J Nutr"},{"key":"2020071614065270600_R261","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2337\/diabetes.50.9.2013","article-title":"Calpains play a role in insulin secretion and action.","volume":"50","author":"Sreenan","year":"2001","journal-title":"Diabetes"},{"key":"2020071614065270600_R262","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/79876","article-title":"Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.","volume":"26","author":"Horikawa","year":"2000","journal-title":"Nat Genet"},{"key":"2020071614065270600_R263","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/jcem.87.4.8385","article-title":"Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R264","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1210\/jcem.87.6.8608","article-title":"Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome.","volume":"87","author":"Haddad","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R265","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0015-0282(01)03206-X","article-title":"Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism.","volume":"77","author":"Escobar-Morreale","year":"2002","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R266","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jcem.87.8.8793","article-title":"CAPN10 alleles are associated with polycystic ovary syndrome.","volume":"87","author":"Gonza\u0301lez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R267","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1210\/jc.2003-030322","article-title":"Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.","volume":"88","author":"Gonza\u0301lez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R268","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2265.1996.658474.x","article-title":"Polymorphism of glycogen synthetase gene in polycystic ovary syndrome.","volume":"44","author":"Rajkhowa","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614065270600_R269","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2337\/diabetes.52.1.214","article-title":"Variation in resistin gene promoter not associated with polycystic ovary syndrome.","volume":"52","author":"Urbanek","year":"2003","journal-title":"Diabetes"},{"key":"2020071614065270600_R270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/molehr\/6.10.873","article-title":"No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome.","volume":"6","author":"Oksanen","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"2020071614065270600_R271","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0015-0282(01)01691-0","article-title":"Apolipoprotein E alleles in women with polycystic ovary syndrome.","volume":"75","author":"Heinonen","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R272","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9343(98)00184-3","article-title":"Biologic markers as predictors of cardiovascular disease.","volume":"104","author":"Frishman","year":"1998","journal-title":"Am J Med"},{"key":"2020071614065270600_R273","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2002-0010","article-title":"Insulin resistance and chronic cardiovascular inflammatory syndrome.","volume":"24","author":"Fernandez-Real","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071614065270600_R274","first-page":"272","article-title":"Circulating tumor necrosis factor-\u03b1 concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.","volume":"84","author":"Zinman","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R275","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diabetes.47.11.1757","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.","volume":"47","author":"Fernandez-Real","year":"1998","journal-title":"Diabetes"},{"key":"2020071614065270600_R276","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jcem.86.9.7873","article-title":"Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study.","volume":"86","author":"Hak","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R277","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-\u03b1 in human obesity and insulin resistance.","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071614065270600_R278","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2337\/diab.46.3.451","article-title":"Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.","volume":"46","author":"Hotamisligil","year":"1997","journal-title":"Diabetes"},{"key":"2020071614065270600_R279","first-page":"3338","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.","volume":"85","author":"Bastard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R280","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance.","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"2020071614065270600_R281","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"2020071614065270600_R282","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.8755-8920.2000.440203.x","article-title":"Alteration of cytokine production in follicular cystic ovaries induced in mice by neonatal estradiol injection.","volume":"44","author":"Deshpande","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"2020071614065270600_R283","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0015-0282(03)00344-3","article-title":"Correlations between concentrations of interleukin-12 and interleukin-13 and lymphocyte subsets in the follicular fluid of women with and without polycystic ovary syndrome.","volume":"79","author":"Gallinelli","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R284","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome.","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R285","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R286","first-page":"1177","article-title":"Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles.","volume":"101","author":"Amato","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2020071614065270600_R287","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor \u03b1 in normal-weight women with polycystic ovary syndrome.","volume":"48","author":"Gonza\u0301lez","year":"1999","journal-title":"Metabolism"},{"key":"2020071614065270600_R288","first-page":"3761","article-title":"TNF-\u03b1 and hyperandrogenism: a clinical, biochemical, and molecular genetic study.","volume":"86","author":"Escobar-Morreale","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R289","first-page":"165","article-title":"Elevated serum TNF-\u03b1 levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome.","volume":"48","author":"Sayin","year":"2003","journal-title":"J Reprod Med"},{"key":"2020071614065270600_R290","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00125-003-1090-z","article-title":"Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.","volume":"46","author":"Escobar-Morreale","year":"2003","journal-title":"Diabetologia"},{"key":"2020071614065270600_R291","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/eje.0.1500525","article-title":"The polycystic ovary syndrome per se is not associated with increased chronic inflammation.","volume":"150","author":"Mohlig","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071614065270600_R292","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.","volume":"89","author":"Escobar-Morreale","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R293","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1095\/biolreprod61.4.993","article-title":"Tumor necrosis factor-\u03b1 stimulates proliferation of rat ovarian theca-interstitial cells.","volume":"61","author":"Spaczynski","year":"1999","journal-title":"Biol Reprod"},{"key":"2020071614065270600_R294","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/endo-126-5-2711","article-title":"Effects of tumor necrosis factor-\u03b1 in vitro on steroidogenesis of healthy and atretic follicles of the rat: theca as a target.","volume":"126","author":"Roby","year":"1990","journal-title":"Endocrinology"},{"key":"2020071614065270600_R295","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1210\/endo.137.11.8895358","article-title":"Tumor necrosis factor-\u03b1 and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles.","volume":"137","author":"Kaipia","year":"1996","journal-title":"Endocrinology"},{"key":"2020071614065270600_R296","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/molehr\/5.1.5","article-title":"No association between the \u2212308 polymorphism in the tumor necrosis factor \u03b1 (TNF\u03b1) promoter region and polycystic ovaries.","volume":"5","author":"Milner","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"2020071614065270600_R297","first-page":"536","article-title":"Study on the relationship between a polymorphism of tumor necrosis factor-\u03b1 gene and the pathogenesis of polycystic ovary syndrome.","volume":"35","author":"Mao","year":"2000","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2020071614065270600_R298","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/gye.16.4.271.274","article-title":"Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-\u03b1 and polycystic ovary syndrome.","volume":"16","author":"Korhonen","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"2020071614065270600_R299","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families.","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R300","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2337\/diacare.23.6.831","article-title":"Polymorphism of the tumor necrosis factor-\u03b1 receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients.","volume":"23","author":"Fernandez-Real","year":"2000","journal-title":"Diabetes Care"},{"key":"2020071614065270600_R301","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/9.14.2067","article-title":"Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.","volume":"9","author":"Geurts","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R302","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/hmg\/9.13.1943","article-title":"Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor.","volume":"9","author":"Glenn","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020071614065270600_R303","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s001090000168","article-title":"Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease.","volume":"79","author":"Benjafield","year":"2001","journal-title":"J Mol Med"},{"key":"2020071614065270600_R304","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/diacare.24.4.753","article-title":"TNFRSF1B in genetic predisposition to clinical neuropathy and effect on HDL cholesterol and glycosylated hemoglobin in type 2 diabetes.","volume":"24","author":"Benjafield","year":"2001","journal-title":"Diabetes Care"},{"key":"2020071614065270600_R305","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/jcem.85.3.6582","article-title":"Interleukin-6: the endocrine cytokine.","volume":"85","author":"Papanicolaou","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R306","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jcem.85.3.6555","article-title":"Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects.","volume":"85","author":"Fernandez-Real","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R307","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diabetes.49.3.517","article-title":"Interleukin-6 gene polymorphism and insulin sensitivity.","volume":"49","author":"Fernandez-Real","year":"2000","journal-title":"Diabetes"},{"key":"2020071614065270600_R308","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/jcem.86.3.7305","article-title":"Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.","volume":"86","author":"Fernandez-Real","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R309","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1034\/j.1600-0412.2003.00045.x","article-title":"Differential expression of T-helper cytokines in the peritoneal fluid of women with normal ovarian cycle compared with women with chronic anovulation.","volume":"82","author":"Omu","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2020071614065270600_R310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bj3610105","article-title":"Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.","volume":"361","author":"Haan","year":"2002","journal-title":"Biochem J"},{"key":"2020071614065270600_R311","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/endo-128-6-3313","article-title":"Follistatin binds to both activin and inhibin through the common subunit.","volume":"128","author":"Shimonaka","year":"1991","journal-title":"Endocrinology"},{"key":"2020071614065270600_R312","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3181\/00379727-215-44130","article-title":"Activins, inhibins, and follistatins: further thoughts on a growing family of regulators.","volume":"215","author":"Mather","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071614065270600_R313","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/jme.0.0160249","article-title":"Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic \u03b2-cell lines.","volume":"16","author":"Shibata","year":"1996","journal-title":"J Mol Endocrinol"},{"key":"2020071614065270600_R314","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1095\/biolreprod48.1.15","article-title":"An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis.","volume":"48","author":"Findlay","year":"1993","journal-title":"Biol Reprod"},{"key":"2020071614065270600_R315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/mend.12.1.0053","article-title":"Overexpression of mouse follistatin causes reproductive defects in transgenic mice.","volume":"12","author":"Guo","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2020071614065270600_R316","first-page":"1434","article-title":"Expression of inhibin\/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.","volume":"79","author":"Roberts","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R317","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1677\/joe.0.1430127","article-title":"Expression of inhibin \u03b1, \u03b2A and \u03b2B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome.","volume":"143","author":"Jaatinen","year":"1994","journal-title":"J Endocrinol"},{"key":"2020071614065270600_R318","first-page":"4455","article-title":"Allelic variants of the follistatin gene in polycystic ovary syndrome.","volume":"85","author":"Urbanek","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R319","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/molehr\/6.7.587","article-title":"Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome.","volume":"6","author":"Liao","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"2020071614065270600_R320","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0015-0282(01)01697-1","article-title":"Role of the follistatin gene in women with polycystic ovary syndrome.","volume":"75","author":"Calvo","year":"2001","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R321","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9150(98)00281-0","article-title":"Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-\u03b1?","volume":"143","author":"Cigolini","year":"1999","journal-title":"Atherosclerosis"},{"key":"2020071614065270600_R322","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1073\/pnas.96.12.6902","article-title":"Tumor necrosis factor \u03b1 is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.","volume":"96","author":"Samad","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614065270600_R323","doi-asserted-by":"crossref","first-page":"C1391","DOI":"10.1152\/ajpcell.1999.276.6.C1391","article-title":"TNF-\u03b1 and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes","volume":"276","author":"Sakamoto","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071614065270600_R324","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R325","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00125-001-0774-5","article-title":"The common \u2212675 4G\/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity.","volume":"45","author":"Hoffstedt","year":"2002","journal-title":"Diabetologia"},{"key":"2020071614065270600_R326","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"2020071614065270600_R327","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/17.2.314","article-title":"Polycystic ovarian syndrome and thrombophilia.","volume":"17","author":"Tsanadis","year":"2002","journal-title":"Hum Reprod"},{"key":"2020071614065270600_R328","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2002-021142","article-title":"Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome.","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R329","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0015-0282(03)00385-6","article-title":"Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome.","volume":"79","author":"Korhonen","year":"2003","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R330","first-page":"323","article-title":"The role of bone morphogenetic proteins in ovarian function.","volume":"61","author":"Shimasaki","year":"2003","journal-title":"Reprod Suppl"},{"key":"2020071614065270600_R331","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0015-0282(00)01539-9","article-title":"Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome.","volume":"74","author":"Takebayashi","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071614065270600_R332","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s001250051451","article-title":"Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype\/phenotype to thriftiness.","volume":"42","author":"Fernandez-Real","year":"1999","journal-title":"Diabetologia"},{"key":"2020071614065270600_R333","first-page":"2097","article-title":"Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"82","author":"Witchel","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614065270600_R334","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1025619510292","article-title":"Success in mating: a coordinated approach to fitness through genotypes incorporating genes for stress resistance and heterozygous advantage under stress.","volume":"27","author":"Parsons","year":"1997","journal-title":"Behav Genet"},{"key":"2020071614065270600_R335","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1073\/pnas.97.7.3309","article-title":"Experimental evolution of aging, growth, and reproduction in fruitflies.","volume":"97","author":"Stearns","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614065270600_R336","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJM198501313120505","article-title":"Paleolithic nutrition. A consideration of its nature and current implications.","volume":"312","author":"Eaton","year":"1985","journal-title":"N Engl J Med"},{"key":"2020071614065270600_R337","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-9343(88)90113-1","article-title":"Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective.","volume":"84","author":"Eaton","year":"1988","journal-title":"Am J Med"},{"key":"2020071614065270600_R338","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/diab.40.2.161","article-title":"Archaeology of NIDDM. Excavation of the \u201cthrifty\u201d genotype.","volume":"40","author":"Wendorf","year":"1991","journal-title":"Diabetes"},{"key":"2020071614065270600_R339","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00041433-200302000-00009","article-title":"Cardiovascular disease genetics: a long and winding road.","volume":"14","author":"Ordovas","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"2020071614065270600_R340","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/301928","article-title":"Inflation of sibling recurrence-risk ratio, due to ascertainment bias and\/or overreporting.","volume":"63","author":"Guo","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R341","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1086\/339517","article-title":"Ascertainment-adjusted parameter estimates revisited.","volume":"70","author":"Epstein","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R342","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-139-5_Part_2-200309021-00011","article-title":"Gene-environment interactions and the etiology of common complex disease.","volume":"139","author":"Cooper","year":"2003","journal-title":"Ann Intern Med"},{"key":"2020071614065270600_R343","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1534\/genetics.166.4.1963","article-title":"Sibship reconstruction from genetic data with typing errors.","volume":"166","author":"Wang","year":"2004","journal-title":"Genetics"},{"key":"2020071614065270600_R344","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.ejhg.5201164","article-title":"Detection of genotyping errors by Hardy-Weinberg equilibrium testing.","volume":"12","author":"Hosking","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"2020071614065270600_R345","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1086\/382284","article-title":"Incorporating genotyping uncertainty in haplotype inference for single-nucleotide polymorphisms.","volume":"74","author":"Kang","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2020071614065270600_R346","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0888-7543(87)90098-X","article-title":"A new discipline, a new name, a new journal.","volume":"1","author":"McKusick","year":"1985","journal-title":"Genomics"},{"key":"2020071614065270600_R347","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00041433-200304000-00001","article-title":"\u2018Omic\u2019 approaches and lipid metabolism: are these new technologies holding their promises?","volume":"14","author":"Mooser","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"2020071614065270600_R348","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0952-7915(99)80078-8","article-title":"Host genetic influences on HIV-1 pathogenesis.","volume":"11","author":"Michael","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"2020071614065270600_R349","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.58.2.179","article-title":"Recent advances in the genetics and pathogenesis of Parkinson disease.","volume":"58","author":"Mouradian","year":"2002","journal-title":"Neurology"},{"key":"2020071614065270600_R350","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2008-1040852","article-title":"Molecular genetics of Alzheimer disease.","volume":"19","author":"St George-Hyslop","year":"1999","journal-title":"Semin Neurol"},{"key":"2020071614065270600_R351","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1126\/science.1076641","article-title":"Finding genes that underlie complex traits.","volume":"298","author":"Glazier","year":"2002","journal-title":"Science"},{"key":"2020071614065270600_R352","doi-asserted-by":"crossref","first-page":"26380","DOI":"10.1074\/jbc.M300688200","article-title":"The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.","volume":"278","author":"Wood","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071614065270600_R353","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/elps.1150180333","article-title":"A comparison of selected mRNA and protein abundances in human liver.","volume":"18","author":"Anderson","year":"1997","journal-title":"Electrophoresis"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/26\/2\/251\/8861921\/edrv0251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/26\/2\/251\/8861921\/edrv0251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:56:06Z","timestamp":1683053766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/26\/2\/251\/2683828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":353,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2004-0004","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}